104 related articles for article (PubMed ID: 8997073)
1. [Prognostic significance of carcinoma in situ and epithelial dysplasia accompanying bladder cancers].
Wajiki M
Nihon Hinyokika Gakkai Zasshi; 1996 Dec; 87(12):1269-76. PubMed ID: 8997073
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer.
Kakizoe T; Matsumoto K; Nishio Y; Kishi K
J Urol; 1984 Mar; 131(3):467-72. PubMed ID: 6699986
[TBL] [Abstract][Full Text] [Related]
3. [A study of dysplasia associated with bladder cancer--histopathological findings of bladder giant sections and related urinary cytology].
Sekine H
Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):545-54. PubMed ID: 2747096
[TBL] [Abstract][Full Text] [Related]
4. Significance of carcinoma in situ and dysplasia in association with bladder cancer.
Kakizoe T; Matumoto K; Nishio Y; Ohtani M; Kishi K
J Urol; 1985 Mar; 133(3):395-8. PubMed ID: 3973990
[TBL] [Abstract][Full Text] [Related]
5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in local surgical treatment of invasive bladder cancer, with special reference to the presence of urothelial dysplasia.
Wolf H; Højgaard K
Cancer; 1983 May; 51(9):1710-5. PubMed ID: 6831368
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of urothelial dysplasia concomitant with superficial bladder cancer].
Ishii T; Takeuchi F; Hiratsuka Y; Ariyoshi A
Nihon Hinyokika Gakkai Zasshi; 1999 Jun; 90(6):633-8. PubMed ID: 10422439
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guérin immunotherapy.
Kim SJ; You D; Jeong IG; Song C; Hong B; Kim CS; Ahn H; Hong JH
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2131-2140. PubMed ID: 31227894
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
10. Examination of tumorigenesis of precursor lesions in bladder cancer by in situ hybridization.
Krause S; Feil G; Beiter T; Pressler H; Schrott KM; Bichler KH
Urol Int; 2004; 72(2):118-22. PubMed ID: 14963351
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of carcinoma in situ of the urinary bladder].
Harada Y; Seguchi T; Nonomura N; Kojima Y; Miki T; Okuyama A
Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):693-7. PubMed ID: 9780653
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of papillary and nodular carcinomas in the urinary bladder.
Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis, prognosis and therapeutic results in urothelial dysplasia in patients with bladder cancer].
Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
Orv Hetil; 1984 Jul; 125(31):1875-8, 1881. PubMed ID: 6472835
[No Abstract] [Full Text] [Related]
14. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.
Shariat SF; Pahlavan S; Baseman AG; Brown RM; Green AE; Wheeler TM; Lerner SP
Urology; 2001 Jan; 57(1):60-5. PubMed ID: 11164145
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of denuded urothelium in bladder biopsy.
Levi AW; Potter SR; Schoenberg MP; Epstein JI
J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
[TBL] [Abstract][Full Text] [Related]
16. Nonpapillary lesions of the urinary bladder: a retrospective study.
Schujman E; Mukamel E; Slutzker D; Vilcovsky E; Servadio C
Isr J Med Sci; 1983 Jul; 19(7):619-25. PubMed ID: 6885346
[TBL] [Abstract][Full Text] [Related]
17. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
19. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
[TBL] [Abstract][Full Text] [Related]
20. The risk profiles of three clinical types of carcinoma in situ of the bladder.
Meijer RP; van Onna IE; Kok ET; Bosch R
BJU Int; 2011 Sep; 108(6):839-43. PubMed ID: 21166747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
